CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $37,230,000 | -26.0% | 1,500,000 | -46.4% | 1.86% | -22.3% |
| Q4 2018 | $50,288,000 | -2.2% | 2,800,000 | +60.0% | 2.39% | +8.5% |
| Q3 2018 | $51,398,000 | +13.0% | 1,750,000 | +75.0% | 2.20% | +25.7% |
| Q2 2018 | $45,470,000 | +4.4% | 1,000,000 | +21.2% | 1.75% | -18.2% |
| Q1 2018 | $43,560,000 | +6.8% | 825,000 | +37.5% | 2.14% | +7.1% |
| Q4 2017 | $40,800,000 | +147.6% | 600,000 | +200.0% | 2.00% | +91.3% |
| Q3 2017 | $16,480,000 | – | 200,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |